Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Stock
Stocks
600196
CNE000000X38
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.05 CNY | +1.09% |
|
+3.71% | -9.21% |
| Jul. 01 | Junshi Biosciences Licenses Autoimmune Drug to Fosun Pharma | MT |
| Jun. 30 | Fosun Pharma to Offload Partnership Fund Stake for 1 Million Yuan; Shares Down 4% | MT |
| Market Cap | 58.21B 8.59B 7.51B 6.94B 6.41B 12.08B 826B 12.3B 82.8B 32.49B 404B 32.28B 31.57B 1,392B | P/E 2026 * |
16.3x | P/E 2027 * | 14.3x |
|---|---|---|---|---|---|
| Enterprise Value | 73.33B 10.83B 9.46B 8.75B 8.08B 15.22B 1,040B 15.49B 104B 40.92B 509B 40.67B 39.77B 1,753B | EV / Sales 2026 * |
1.69x | EV / Sales 2027 * | 1.76x |
| Free-Float |
62.77% | Yield 2026 * |
1.85% | Yield 2027 * | 2.13% |
| 1 day | +1.09% | ||
| 1 week | +3.71% | ||
| Current month | +7.03% | ||
| 1 month | +7.56% | ||
| 3 months | -9.11% | ||
| 6 months | -14.32% | ||
| Current year | -9.21% |
| 1 week | 22.47 |  | 24.24 |
| 1 month | 20.85 | | 24.24 |
| Current year | 20.85 | | 28.71 |
| 1 year | 20.85 | | 33.1 |
| 3 years | 20.38 | | 33.1 |
| 5 years | 20.38 | | 91.69 |
| 10 years | 20.38 | | 91.69 |
| Manager | Title | Age | Since |
|---|---|---|---|
Yi Liu
CEO | Chief Executive Officer | 50 | 2025-06-23 |
Zhi Huang
DFI | Director of Finance/CFO | - | 2026-04-01 |
Wen Jie Zhang
PSD | President | 59 | 2023-06-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Qi Yu Chen
CHM | Chairman | 54 | 1994-03-31 |
Yi Min Guan
BRD | Director/Board Member | 76 | 2014-05-31 |
Yi Liu
BRD | Director/Board Member | 50 | 2025-12-01 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25-05-29 | Sell | 31,790 | 0.0015% | |||
| 25-05-29 | Sell | Director | 73,168 | 0.0035% | ||
| 25-05-29 | Sell | Chief Executive Officer | 87,448 | 0.0041% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.09% | +3.71% | -6.35% | -22.14% | 8.59B | |
| -2.48% | -6.72% | +44.19% | +156.43% | 1,028B | |
| -1.52% | -5.01% | +61.87% | +58.79% | 611B | |
| -1.30% | -3.88% | +27.81% | +79.97% | 432B | |
| -0.29% | -3.68% | +26.89% | +20.58% | 323B | |
| -0.38% | -3.45% | +26.95% | +44.09% | 277B | |
| -0.47% | -13.55% | +17.28% | +20.69% | 257B | |
| +0.70% | -0.53% | -25.78% | -40.03% | 217B | |
| -1.44% | -3.49% | +19.60% | +56.20% | 192B | |
| -1.04% | -4.63% | +16.01% | +68.47% | 161B | |
| Average | -0.42% | -3.26% | +20.85% | +44.30% | 350.69B | |
| Weighted average by Cap. | -0.47% | -4.73% | +33.24% | +76.55% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 43.19B 6.38B 5.57B 5.15B 4.76B 8.96B 613B 9.13B 61.44B 24.11B 300B 23.96B 23.43B 1,033B | 44.59B 6.58B 5.75B 5.32B 4.91B 9.25B 632B 9.42B 63.42B 24.88B 310B 24.73B 24.18B 1,066B |
| Net income | 3.87B 571M 499M 461M 426M 802M 54.82B 817M 5.5B 2.16B 26.84B 2.14B 2.1B 92.43B | 4.27B 631M 551M 510M 471M 887M 60.59B 903M 6.08B 2.38B 29.67B 2.37B 2.32B 102B |
| Net Debt | 15.12B 2.23B 1.95B 1.8B 1.67B 3.14B 214B 3.19B 21.51B 8.44B 105B 8.39B 8.2B 362B | 18.28B 2.7B 2.36B 2.18B 2.01B 3.79B 259B 3.86B 26B 10.2B 127B 10.14B 9.91B 437B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-14 | CN¥24.05 | +1.09% | 39,577,476 |
| 26-07-13 | CN¥23.79 | +1.45% | 37,517,578 |
| 26-07-10 | CN¥23.45 | +2.18% | 37,760,611 |
| 26-07-09 | CN¥22.95 | 0.00% | 26,662,927 |
| 26-07-08 | CN¥22.95 | -1.03% | 23,866,241 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600196 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
